Indicators of malignancy of canine adrenocortical tumors: Histopathology and proliferation index

Veterinary Pathology

Volumn 41, Issue 5, 2004, Pages 490-497

  Labelle, P ^a   Kyles, A E ^a   Farver, T B ^a   De Cock, H E V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenal gland; Adrenocortical adenoma; Adrenocortical carcinoma; Dogs; Endocrine diseases; Endocrine system; Histopathology; Immunohistochemistry; Ki 67 antigen; Neoplasms

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN; TUMOR MARKER;

ADENOMA; ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ANIMAL TISSUE; ARTICLE; BLEEDING; CANCER GROWTH; CANCER INVASION; CANCER SIZE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DOG DISEASE; FEMALE; FIBRIN CLOT; FIBROSIS; HEMATOPOIESIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NECROSIS; NONHUMAN; STATISTICAL SIGNIFICANCE;

ADRENAL CORTEX NEOPLASMS; ANIMALS; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOPLASMS, GLANDULAR AND EPITHELIAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 4644353744     PISSN: 03009858     EISSN: None     Source Type: Journal    
DOI: 10.1354/vp.41-5-490     Document Type: Article

References (35)

1. Abadie JJ, Amardeilh MA, Delverdier ME: Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 215:1629-1634, 1999
2. Arola J, Salmenkivi K, Liu J, Kahri AI, Heikkila P: p53 and Ki67 in adrenocortical tumors. Endocr Res 26:861-865, 2000
3. Bernini GP, Moretti A, Viacava P, Bonadio AG, Iacconi P, Miccoli P, Salvetti A: Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues. Br J Cancer 86:1561-1565, 2002
4. Capen CC: Tumors of the endocrine glands. In: Tumors in Domestic Animals, ed. Meuten DJ, 4th ed., pp. 607-696. Iowa State Press, Ames, IA, 2002
5. Edgren M, Eriksson B, Wilander E, Westlin JE, Nilsson S, Oberg K: Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas. Anticancer Res 17:1303-1309, 1997
6. Evans HL, Vassilopoulou-Sellin R: Adrenal cortical neoplasms. A study of 56 cases. Am J Clin Pathol 105:76-86, 1996
7. Feldman EC: Hyperadrenocorticism. In: Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat, ed. Ettinger SJ and Feldman EC, 5th ed., pp. 1460-1487. WB Saunders, Philadelphia, PA, 2000
8. Goetz SP, Niemann TH, Robinson RA, Cohen MB: Hematopoietic elements associated with adrenal glands. A study of the spectrum of change in nine cases. Arch Pathol Lab Med 118:895-896, 1994
9. Goldblum JR, Shannon R, Kaldjian EP, Thiny M, Davenport R, Thompson N, Lloyd RV: Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Mod Pathol 6:663-668, 1993
10. Gupta D, Shidham V, Holden J, Layfield L: Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms. Appl Immunohistochem Mol Morphol 9:215-221, 2001
11. Hough AJ, Hollifield JW, Page DL, Hartmann WH: Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol 72:390-399, 1979
12. Iino K, Sasano H, Yabuki N, Oki Y, Kikuchi A, Yoshimi T, Nagura H: DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas. Mod Pathol 10:901-907, 1997
13. Jones TC, Hunt RD, King NW: Endocrine glands. In: Veterinary Pathology, ed. Jones TC, Hunt RD, and King NW, 6th ed., pp. 1249-1250. Lippincott Williams and Wilkins, Baltimore, MD, 1997
14. Kelly DF, Siegel ET, Berg P: The adrenal gland in dogs with hyperadrenocorticalism. A pathologic study. Vet Pathol 8:385-400, 1971
15. Madewell BR: Cellular proliferation in tumors: a review of methods, interpretation, and clinical applications. J Vet Intern Med 15:334-340, 2001
16. McNicol AM, Struthers AL, Nolan CE, Hermans J, Haak HR: Proliferation in adrenocortical tumors: correlation with clinical outcome and p53 status. Endocr Pathol 8:29-36, 1997
17. Medeiros LJ, Weiss LM: New developments in the pathologic diagnosis of adrenal cortical neoplasms. A review. Am J Clin Pathol 97:73-83, 1992
18. Nakazumi H, Sasano H, Iino K, Ohashi Y, Orikasa S: Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms. Mod Pathol 11:1165-1170, 1998
19. Olivry T, Naydan DK, Moore PF: Characterization of the cutaneous inflammatory infiltrate in canine atopic dermatitis. Am J Dermatopathol 19:477-486, 1997
20. Osborn M, Smith M, Senbanjo T, Crofton M, Robinson S, Rajan P: Adrenal myelolipoma - clinical, radiological and cytological findings: a case report. Cytopathology 13:242-246, 2002
21. Pena LL, Nieto AI, Perez-Alenza D, Cuesta P, Castano M: Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. J Vet Diagn Invest 10:237-246, 1998
22. Reusch CE, Feldman EC: Canine hyperadrenocorticism due to adrenocortical neoplasia. Pretreatment evaluation of 41 dogs. J Vet Intern Med 5:3-10, 1991
23. Roels S, Tilmant K, Ducatelle R: PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs. J Comp Pathol 121:13-24, 1999
24. Sakai H, Noda A, Shirai N, Iidaka T, Yanai T, Masegi T, Shirai N, Iidaka T, Yanai T, Masegi T: Proliferative activity of canine mast cell tumours evaluated by bromodeoxyuridine incorporation and Ki-67 expression. J Comp Pathol 127:233-238, 2002
25. Sasano H, Imatani A, Shizawa S, Suzuki T, Nagura H: Cell proliferation and apoptosis in normal and pathologic human adrenal. Mod Pathol 8:11-17, 1995
26. Sasano H, Suzuki T, Moriya T: Discerning malignancy in resected adrenocortical neoplasms. Endocr Pathol 12:397-406, 2001
27. Stojadinovic A, Ghossein RA, Hoos A, Nissan A, Marshall D, Dudas M, Cordon-Cardo C, Jaques DP, Brennan MF: Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 20:941-950, 2002
28. Terzolo M, Boccuzzi A, Bovio S, Cappia S, De Giuli P, Ali A, Paccotti P, Porpiglia F, Fontana D, Angeli A: Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors. Urology 57:176-182, 2001
29. van Slooten H, Schaberg A, Smeenk D, Moolenaar AJ: Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 55:766-773, 1985
30. Vargas MP, Vargas HI, Kleiner DE, Merino MJ: Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB. Am J Surg Pathol 21:556-562, 1997
31. Vrezas I, Wentworth P, Bornstein SR: Myelolipomatous foci in an adrenal adenoma causing Cushing's syndrome? Endocr Res 29:67-71, 2003
32. Wachenfeld C, Beuschlein F, Zwermann O, Mora P, Fassnacht M, Allolio B, Reincke M: Discerning malignancy in adrenocortical tumors: are molecular markers useful? Eur J Endocrinol 145:335-341, 2001
33. Weiss LM: Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163-169, 1984
34. Weiss LM, Medeiros LJ, Vickery AL Jr: Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202-206, 1989
35. Yarrington JT, Capen CC: Changes in the structure and function of the adrenal gland. In: Pathobiology of the Aging Dog, ed. Mohr U, Carlton WW, Dungworth DL, Benjamin SA, Capen CC, and Hahn FF, 1st ed., pp. 273-284. Iowa State Press, Ames, IA, 2001